Fangyan Gao

300, Guangzhou Road
Nanjing, 210029, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer.

Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer.

Journal: Clinical and translational medicine

Published: May 25, 2025

AR/ERK co-targeting triggers ferroptosis via FOXC2 in triple-negative breast cancer.

AR/ERK co-targeting triggers ferroptosis via FOXC2 in triple-negative breast cancer.

Journal: Science China. Life sciences

Published: March 27, 2025

Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer.

Precise nano-system-based drug delivery and synergistic therapy against androgen receptor-positive triple-negative breast cancer.

Journal: Acta pharmaceutica Sinica. B

Published: December 25, 2023

Cell-cell communication characteristics in breast cancer metastasis.

Cell-cell communication characteristics in breast cancer metastasis.

Journal: Cell communication and signaling : CCS

Published: August 02, 2023

Ultrasound-responsive spherical nucleic acid against c-Myc/PD-L1 to enhance anti-tumoral macrophages in triple-negative breast cancer progression.

Ultrasound-responsive spherical nucleic acid against c-Myc/PD-L1 to enhance anti-tumoral macrophages in triple-negative breast cancer progression.

Journal: Science China. Life sciences

Published: July 12, 2023

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer.

Inhibition of MYC suppresses programmed cell death ligand-1 expression and enhances immunotherapy in triple-negative breast cancer.

Journal: Chinese medical journal

Published: December 30, 2022

Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes.

Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes.

Journal: Acta biochimica et biophysica Sinica

Published: September 23, 2022

Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer.

Clinical considerations of CDK4/6 inhibitors in triple-negative breast cancer.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: April 29, 2021

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis.

Single-cell RNA sequencing reveals cell heterogeneity and transcriptome profile of breast cancer lymph node metastasis.

Journal: Oncogenesis

Published: April 20, 2021

Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting.

Efficacy and acquired resistance of EGFR-TKI combined with chemotherapy as first-line treatment for Chinese patients with advanced non-small cell lung cancer in a real-world setting.

Journal: BMC cancer

Published: October 25, 2020

Checkpoint inhibitor pneumonitis in Chinese lung cancer patients: clinical characteristics and risk factors.

Checkpoint inhibitor pneumonitis in Chinese lung cancer patients: clinical characteristics and risk factors.

Journal: Annals of palliative medicine

Published: August 25, 2020

RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma.

RNA methyltransferase METTL3 induces intrinsic resistance to gefitinib by combining with MET to regulate PI3K/AKT pathway in lung adenocarcinoma.

Journal: Journal of cellular and molecular medicine

Published: July 02, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026